rs138332224

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_030665.4(RAI1):​c.610C>T​(p.Pro204Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00173 in 1,613,912 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 10 hom. )

Consequence

RAI1
NM_030665.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.23
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005404234).
BP6
Variant 17-17793558-C-T is Benign according to our data. Variant chr17-17793558-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 130083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17793558-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0024 (365/152286) while in subpopulation NFE AF= 0.00228 (155/67990). AF 95% confidence interval is 0.00199. There are 2 homozygotes in gnomad4. There are 237 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 365 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RAI1NM_030665.4 linkuse as main transcriptc.610C>T p.Pro204Ser missense_variant 3/6 ENST00000353383.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RAI1ENST00000353383.6 linkuse as main transcriptc.610C>T p.Pro204Ser missense_variant 3/61 NM_030665.4 P1Q7Z5J4-1
RAI1ENST00000395774.1 linkuse as main transcriptc.610C>T p.Pro204Ser missense_variant 2/22

Frequencies

GnomAD3 genomes
AF:
0.00240
AC:
365
AN:
152168
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0182
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00228
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00261
AC:
655
AN:
251070
Hom.:
5
AF XY:
0.00250
AC XY:
340
AN XY:
135794
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0187
Gnomad NFE exome
AF:
0.00186
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00166
AC:
2429
AN:
1461626
Hom.:
10
Cov.:
97
AF XY:
0.00168
AC XY:
1218
AN XY:
727112
show subpopulations
Gnomad4 AFR exome
AF:
0.000119
Gnomad4 AMR exome
AF:
0.000380
Gnomad4 ASJ exome
AF:
0.000689
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0172
Gnomad4 NFE exome
AF:
0.00126
Gnomad4 OTH exome
AF:
0.00127
GnomAD4 genome
AF:
0.00240
AC:
365
AN:
152286
Hom.:
2
Cov.:
33
AF XY:
0.00318
AC XY:
237
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0182
Gnomad4 NFE
AF:
0.00228
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00161
Hom.:
0
Bravo
AF:
0.000756
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.00222
AC:
269
EpiCase
AF:
0.000981
EpiControl
AF:
0.000830

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024RAI1: BP4, BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 24, 2015- -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 20, 2020- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 10, 2018- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 17, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
RAI1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 22, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
6.2
DANN
Benign
0.85
DEOGEN2
Benign
0.087
T;.;.
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.74
T;T;T
MetaRNN
Benign
0.0054
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.38
N;.;.
MutationTaster
Benign
0.95
D;D
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.1
N;N;.
REVEL
Benign
0.034
Sift
Benign
0.50
T;T;.
Sift4G
Benign
0.87
T;T;.
Polyphen
0.0030
B;.;.
Vest4
0.18
MVP
0.13
MPC
0.27
ClinPred
0.0054
T
GERP RS
2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Varity_R
0.045
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138332224; hg19: chr17-17696872; API